Aline Noizet

Digital

Aline Noizet, founder of Digital Health Connector, talks with Deep Dive editor Eloise McLennan about the relationships that make innovation possible.

News

argenx's CD122 inhibitor FB102, added to its pipeline through the $2.2bn acquisition of Forte, is moving into phase 3 testing for coeliac disease.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.